Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bristol-Myers Squibb announces dividend of R$ 2.11 per unit for Q3 2026

Bristol-Myers Squibb announces dividend of R$ 2.11 per unit for Q3 2026

ReutersReuters2026/08/04 12:35
  • Bristol-Myers Squibb set a 3Q 2026 cash distribution of R$ 2.11 per unit (ISIN BRBMYBBDR000).
  • Shares trade with entitlement through July 1, 2026.
  • Payment scheduled for Aug. 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma

GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.

智通财经2026/09/15 08:06
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma